Home | Welcome to Contract Pharma   
Last Updated Thursday, December 18 2014

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 14, 2011
Array BioPharma will restructure in an effort to extend its financial resources to focus on the development of key clinical programs: ARRY-520, a KSP inhibitor for multiple myeloma, ARRY-614, a p38 / Tie-2 inhibitor for myelodysplastic syndrome, and MEK162, a MEK inhibitor for cancer in co-development with Novartis. Read More »
Published March 28, 2011
Peter S. Linsley, Ph.D., has been appointed chief scientific officer of AVI BioPharma, Inc., effective May 1, 2011. Read More »
Published January 7, 2011
Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th. Read More »
Published October 27, 2010
AVI BioPharma, Inc. has made three key leadership appointments to support the expansion of its drug discovery R&D capabilities. Read More »
Published January 21, 2010
AlphaRx Inc.’s licensee, Gaia BioPharma Ltd., has signed an agreement with a CMO to manufacture GAI-122 for use in Phase I and II trials. Read More »
Published April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries. Read More »
Published May 23, 2008
DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official… Read More »
Published March 18, 2008
Gary M. Clark, Ph.D., has joined Array BioPharma, Inc. as vice president of biostatistics and data management. Dr. Clark will oversee the company's biostatistics and data management activities on its growing pipeline of targeted small molecule drugs… Read More »
Published December 13, 2006
Holmes Biopharma, Inc. has signed a letter of intent to purchase an existing pharmaceutical development, clinical manufacture, biotechnology, and analytical laboratory business located in the eastern U.S. The name and terms of the acquisition will be… Read More »
Published October 6, 2006
Array BioPharma, Inc. has appointed April H. Teitelbaum, M.D., MS, FACP, to the newly created position of vice president of clinical development, oncology. Dr. Teitelbaum will oversee the medical strategy and clinical development of the company's onc… Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On